You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:35:45 UTC
Last Updated2019-10-01 21:41:04 UTC
CypComp IDCC01923
Compound Information
NameCyclophosphamide
Structure ImageCmsmoczeivjldb cqszacivsa n
InChIKeyCMSMOCZEIVJLDB-CQSZACIVSA-N
PubChem ID9554282
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • <10,H;Hydroxylation;R1>
  • <6,3;Cleavage;R2>
  • <6,H;Oxidation;R2>
  • <7,3;Cleavage;R3>
  • <7,H;Oxidation;R3>
  • <10,H;Hydroxylation;R1>
  • <10,H;Hydroxylation;R1>
  • <10,H;Hydroxylation;R1>
  • <10,H;Hydroxylation;R1>
  • <10,H;Hydroxylation;R1>
  • Not Available
  • Not Available
  • <10,H;Hydroxylation;R1>
  • <6,3;Cleavage;R2>
  • <6,H;Oxidation;R2>
  • <7,3;Cleavage;R3>
  • <7,H;Oxidation;R3>
References
  1. Roy P, Yu LJ, Crespi CL, Waxman DJ: Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug Metab Dispos. 1999 Jun;27(6):655-66. [PubMed:10348794 ]
  2. Bohnenstengel F, Hofmann U, Eichelbaum M, Kroemer HK: Characterization of the cytochrome P450 involved in side-chain oxidation of cyclophosphamide in humans. Eur J Clin Pharmacol. 1996;51(3-4):297-301. [PubMed:9010702 ]
Download FileCC01923.sdf